Predictors of Readmission in a Period of 30 Days or Less in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Clinical Pulmonary Medicine

Volumn 22, Issue 4, 2015, Pages 172-176

  Crisafulli, Ernesto ^a   Ortega, Sonia ^b   Torres, Antoni ^b  

^a CARLO POMA HOSPITAL   (Italy)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

acute exacerbation; chronic obstructive pulmonary disease; predictors; readmission

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANXIETY DISORDER; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COR PULMONALE; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG USE; HEALTH CARE COST; HEART FAILURE; HEART INFARCTION; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LUNG INFILTRATE; MALNUTRITION; NEOPLASM; OSTEOPOROSIS; PNEUMONIA; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 84936998702     PISSN: 10680640     EISSN: 15365956     Source Type: Journal    
DOI: 10.1097/CPM.0000000000000090     Document Type: Article

References (49)

1. Buist AS, McBurnie MA, Vollmer WM, et al. On behalf of BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741-750.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
3. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204.
4. Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174:867-874.
5. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847-852.
6. Donaldson GC, Wilkinson TMA, Hurst JR, et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:446-452.
7. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157: 1418-1422.
8. Soler-Cataluña JJ, Martìnez-Garcìa MA, Romàn Sànchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925-931.
9. Garcia-Aymerich J, Serra Pons I, Mannino DM, et al. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax. 2011;66:585-590.
10. Niewoehner DE, Lokhnygina Y, Rice K, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007;131:20-28.
11. Hurst JR, Donaldson GC, Quint JK, et al. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179:369-374.
12. Hurst JR, Vestbo J, Anzueto A, et al. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128-1138.
13. Wedzicha JA, Brill SE, Allinson JP, et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013;11:181.
14. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428.
15. Reed RL, Pearlman RA, Buchner DM. Risk factors for early unplanned hospital readmission in the elderly. J Gen Intern Med. 1991;6:223-228.
16. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157:99-104.
17. Friedman B, Jiang HJ, Elixhauser A. Costly hospital readmissions and complex chronic illness. Inquiry. 2008-2009;45:408-421.
18. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and exsmokers. Respir Med. 2007;101:1305-1312.
19. Centers for Disease Control and Prevention (CDC). Deaths from chronic obstructive pulmonary disease. United States, 2000-2005. MMWR Morb Mortal Wkly Rep. 2008;57:1229-1232.
20. Strassels SA, Smith DH, Sullivan SD, et al. The cost of treating COPD in the United States. Chest. 2001;119:344-352.
21. FitzGerald JM, Haddon JM, Bradly-Kennedy C, et al. Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Respir J. 2007;14:145-152.
22. Elixhauser A, Au DH, Podulka J. Readmissions for Chronic Obstructive Pulmonary Disease, 2008: Statistical Brief #121 Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville, MD: Agency for Health Care Policy and Research (US); 2006-2011.
23. Jencks SF. Defragmenting care. Ann Intern Med. 2010;153: 757-758.
24. Zapatero A, Barba R, Ruiz J, et al. Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. J Hum Nutr Diet. 2013;26(suppl 1):16-22.
25. Chan FW, Wong FY, Yam CH, et al. Risk factors of hospitalization and readmission of patients with COPD in Hong Kong population: analysis of hospital admission records. BMC Health Serv Res. 2011;11:186.
26. Sharif R, Parekh TM, Pierson KS, et al. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11:685-694.
27. Liu SF, Lin KC, Chin CH, et al. Factors influencing short-term readmission and one-year mortality in patients with chronic obstructive pulmonary disease. Respirology. 2007;12:560-565.
28. Fidahussein SS, Croghan IT, Cha SS, et al. Posthospital follow-up visits and 30-day readmission rates in chronic obstructive pulmonary disease. Risk Manag Healthc Policy. 2014;7:105-112.
29. Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551-559.
30. Crisafulli E, Torres A, Huerta A, et al. C-reactive protein at discharge, diabetes mellitus and Z1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. COPD. 2014. [Epub ahead of print].
31. Lin J, Xu Y, Wu X, et al. Risk factors associated with chronic obstructive pulmonary disease early readmission. Curr Med Res Opin. 2014;30:315-320.
32. Nantsupawat T, Limsuwat C, Nugent K. Factors affecting chronic obstructive pulmonary disease early rehospitalization. Chron Respir Dis. 2012;9:93-98.
33. Medicare Payment Advisory Commission.2007. Report to the Congress: promoting greater efficiency in Medicare. Medicare Payment Advisory Commission (MedPAC).
34. Chassin MR, Loeb JM, Schmaltz SP, et al. Accountability measures-using measurement to promote quality improvement. N Engl J Med. 2010;363:683-688.
35. CMS.gov. Readmission reduction program. Baltimore, MD: Centers for Medicare and Medicaid Services; revised April 13, 2013. http://www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html 8, 2014
36. Department of Health and Human Services. Centers for Medicare and Medicaid Services. Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long- Term Care Hospital Prospective Payment System and Proposed Fiscal Year 2014 Rates, Quality Reporting Requirements for Specific Providers, Hospital Conditions of Participation. National Archives and Records Administration. 78 Federal Register 91. Available at: http://www.gpo.gov/fdsys/pkg/FR- 2013-05-10/pdf/2013-10234.pdf. Accessed July 8, 2014.
37. Feemster L, Au D. Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med. 2014;189:634-639.
38. Camberg LC, Smith NE, Beaudet M, et al. Discharge destination and repeat hospitalizations. Med Care. 1997;35:756-767.
39. Sin DD, Tu JV. Are elderly patients with obstructive airway disease being prematurely discharged? Am J Respir Crit Care Med. 2000;161:1513-1517.
40. Effing T, Monninkhof EM, van der Valk PD, et al. Self management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007;4: CD002990.
41. Adams SG, Smith PK, Allan PF, et al. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007;167:551-561.
42. Lemmens KM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med. 2009;103:670-691.
43. Smith SM, Allwright S, ODowd T. Effectiveness of shared care across the interface between primary and specialty care in chronic disease management. Cochrane Database Syst Rev. 2007;3: CD004910.
44. Sharma G, Kuo YF, Freeman JL, et al. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010;170:1664-1670.
45. Sorknaes AD, Madsen H, Hallas J, et al. Nurse tele-consultations with discharged COPD patients reduce early readmissions-an interventional study. Clin Respir J. 2011;5:26-34.
46. Hansen LO, Young RS, Hinami K, et al. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med. 2011;155:520-528.
47. Hansen LO, Greenwald JL, Budnitz T, et al. On behalf of project BOOST: effectiveness of a multihospital effort to reduce rehospitalization. J Hosp Med. 2013;8:421-427.
48. Prieto-Centurion V, Markos MA, Ramey NI, et al. Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review. Ann Am Thorac Soc. 2014;11:417-424.
49. Shams I, Ajorlou S, Yang K. A predictive analytics approach to reducing 30-day avoidable readmissions among patients with heart failure, acute myocardial infarction, pneumonia, or COPD. Health Care Manag Sci. 2015;18:19-34.